CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma. [electronic resource]
Producer: 20040610Description: 3105-14 p. digitalISSN:- 1078-0432
- Animals
- Antineoplastic Agents -- therapeutic use
- Cell Line, Tumor
- CpG Islands
- Cyclophosphamide -- therapeutic use
- Disease Models, Animal
- Drug Synergism
- Female
- Immunohistochemistry
- Male
- Mice
- Mice, Inbred C57BL
- Neoplasms, Experimental -- drug therapy
- Oligonucleotides -- therapeutic use
- Rhabdomyosarcoma, Embryonal -- genetics
- T-Lymphocytes -- metabolism
- Time Factors
- Topotecan -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.